Australia markets closed
  • ALL ORDS

    6,720.40
    -26.10 (-0.39%)
     
  • ASX 200

    6,539.90
    -28.20 (-0.43%)
     
  • AUD/USD

    0.6818
    -0.0087 (-1.25%)
     
  • OIL

    108.46
    +2.70 (+2.55%)
     
  • GOLD

    1,812.90
    +5.60 (+0.31%)
     
  • BTC-AUD

    28,219.46
    -1,896.18 (-6.30%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • AUD/EUR

    0.6533
    -0.0048 (-0.73%)
     
  • AUD/NZD

    1.0973
    -0.0077 (-0.70%)
     
  • NZX 50

    10,753.16
    -115.54 (-1.06%)
     
  • NASDAQ

    11,585.68
    +81.96 (+0.71%)
     
  • FTSE

    7,168.65
    -0.63 (-0.01%)
     
  • Dow Jones

    31,097.26
    +321.83 (+1.05%)
     
  • DAX

    12,813.03
    +29.26 (+0.23%)
     
  • Hang Seng

    21,859.79
    -137.10 (-0.62%)
     
  • NIKKEI 225

    25,935.62
    -457.42 (-1.73%)
     

Arielle Zuckerberg On Her First Six Months In VC At KPCB

Harry Stebbings is the founder and host of The Twenty Minute VC , an independent podcast focused on venture capital.

More posts by this contributor

Following TC's article last November reporting on Arielle Zuckerberg's entrance into the world of venture with Kleiner Perkins, we thought it would be fascinating to check in with her to see how her first 6 months in venture has been.

In what turned out to be a refreshingly honest interview we discussed the hardest elements of the transition in venture; what skills Arielle successfully took from her angel investing and product management background to KPCB; how she evaluates product and her learning process for developing new skills.

Our wide-ranging discussion also touched on how Zuckerberg believes AI will be embedded into all products; what makes a great founder; and how individuals wishing to enter the venture industry can position themselves well. She even chatted about her infamous acapella moon walk at KPCB's Monday morning meeting!

https://tcprotectedembed.com/protected-iframe/328d989016c0090a405e271bf0b4e8a0-24588526-59254947 ( function() { var func = function() { var iframe = document.getElementById('wpcom-iframe-328d989016c0090a405e271bf0b4e8a0-24588526-59254947') if ( iframe ) { iframe.onload = function() { iframe.contentWindow.postMessage( { 'msg_type': 'poll_size', 'frame_id': 'wpcom-iframe-328d989016c0090a405e271bf0b4e8a0-24588526-59254947' }, "https:\/\/tcprotectedembed.com" ); } } // Autosize iframe var funcSizeResponse = function( e ) { var origin = document.createElement( 'a' ); origin.href = e.origin; // Verify message origin if ( 'tcprotectedembed.com' !== origin.host ) return; // Verify message is in a format we expect if ( 'object' !== typeof e.data || undefined === e.data.msg_type ) return; switch ( e.data.msg_type ) { case 'poll_size:response': var iframe = document.getElementById( e.data._request.frame_id ); if ( iframe && '' === iframe.width ) iframe.width = '100%'; if ( iframe && '' === iframe.height ) iframe.height = parseInt( e.data.height ); return; default: return; } } if ( 'function' === typeof window.addEventListener ) { window.addEventListener( 'message', funcSizeResponse, false ); } else if ( 'function' === typeof window.attachEvent ) { window.attachEvent( 'onmessage', funcSizeResponse ); } } if (document.readyState === 'complete') { func.apply(); /* compat for infinite scroll */ } else if ( document.addEventListener ) { document.addEventListener( 'DOMContentLoaded', func, false ); } else if ( document.attachEvent ) { document.attachEvent( 'onreadystatechange', func ); } } )();

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting